| Financial Year |
March 31 2023 |
| Monetary Funds |
477,304,962.66 |
| Held-for-trading Financial Assets |
566,296,562.04 |
| Notes Receivable |
17,841,326.18 |
| Accounts Receivable |
1,260,018,491.35 |
| Advances to Suppliers |
17,247,241.51 |
| Other Receivables |
15,597,505.93 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
47,175,800.78 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
40,000,000.00 |
| Total Current Assets |
2,448,726,040.54 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
18,370,994.94 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,708,042.21 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
6,952,209.00 |
| Deferred Income Tax Assets |
33,946,338.16 |
| Other Non-Current Assets |
580,862.65 |
| Sub-Total of Non-Current Assets |
112,578,410.76 |
| Total Assets |
2,561,304,451.30 |
| Short-Term Loans |
151,985,390.00 |
| Trading Financial liabilities |
1,565,400.26 |
| Notes Payable |
-- |
| Accounts Payable |
5,361,296.60 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
284,373,570.81 |
| Taxes Payable |
61,443,325.90 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
13,748,775.27 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
24,784,067.60 |
| Other Current Liabilities |
1,489,762.72 |
| Sub-Total of Current Liabilities |
569,580,967.85 |
| Long-term Loans |
-- |
| Bonds Payable |
454,544,910.23 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
483,010,736.88 |
| Total Liabilities |
1,052,591,704.73 |
| Paid-In Capital(Or Share Stock) |
374,736,587.00 |
| Capital Surplus |
440,979,236.79 |
| Surplus Reserve |
63,132,464.31 |
| LESS:Treasury Stock |
39,001,609.93 |
| Undistributed Profits |
524,425,487.62 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,508,712,746.57 |
| Owner's Equity（Stockholder's Equity） |
1,508,712,746.57 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,561,304,451.30 |
